In an effort to bring clarity to the use of biosimilars in Europe, health authorities have issued a statement confirming their interchangeability with reference 20 September 2022
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended authorising an adapted bivalent vaccine targeting t 13 September 2022
Health authorities in Europe have urged countries to use newly-authorized adapted COVID-19 vaccines as part of autumn and winter vaccination campaigns. 7 September 2022
The Pharmacovigilance Risk Assessment Committee (PRAC). has recommended new measures to minimise the risk of meningioma with medicines containing nomegestrol o 2 September 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.